DE60122306D1 - Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen - Google Patents

Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen

Info

Publication number
DE60122306D1
DE60122306D1 DE60122306T DE60122306T DE60122306D1 DE 60122306 D1 DE60122306 D1 DE 60122306D1 DE 60122306 T DE60122306 T DE 60122306T DE 60122306 T DE60122306 T DE 60122306T DE 60122306 D1 DE60122306 D1 DE 60122306D1
Authority
DE
Germany
Prior art keywords
antibody
antibodies specific
zymogen
inactive
free psa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60122306T
Other languages
English (en)
Other versions
DE60122306T2 (de
Inventor
Jean-Philippe Charrier
Colette Jolivet-Reynaud
Sandrine Michel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of DE60122306D1 publication Critical patent/DE60122306D1/de
Application granted granted Critical
Publication of DE60122306T2 publication Critical patent/DE60122306T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60122306T 2000-04-10 2001-04-10 Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen Expired - Lifetime DE60122306T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0004591 2000-04-10
FR0004591A FR2807438B1 (fr) 2000-04-10 2000-04-10 Nouveaux anticorps reconnaissant specifiquement le psa libre inactif, et leurs applications
PCT/FR2001/001094 WO2001077180A1 (fr) 2000-04-10 2001-04-10 Anticorps reconnaissant specifiquement le psa inactif, et leurs applications

Publications (2)

Publication Number Publication Date
DE60122306D1 true DE60122306D1 (de) 2006-09-28
DE60122306T2 DE60122306T2 (de) 2007-08-30

Family

ID=8849094

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60122306T Expired - Lifetime DE60122306T2 (de) 2000-04-10 2001-04-10 Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen

Country Status (10)

Country Link
US (2) US20030153017A1 (de)
EP (1) EP1272525B1 (de)
AT (1) ATE336513T1 (de)
AU (1) AU2001250470A1 (de)
CA (1) CA2405637A1 (de)
DE (1) DE60122306T2 (de)
ES (1) ES2269376T3 (de)
FR (1) FR2807438B1 (de)
PT (1) PT1272525E (de)
WO (1) WO2001077180A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325483D0 (en) * 2003-10-31 2003-12-03 Plasmacute As Assay
CN1926433A (zh) * 2004-03-03 2007-03-07 拜奥默里克斯公司 用于检测psa的可活化游离形式的方法及其用于诊断前列腺的良性病理学和前列腺的腺癌的用途
DE102007028659A1 (de) * 2007-06-21 2008-12-24 Siemens Ag Diagnosesubstanz und Verfahren zur Diagnose von Prostataerkrankungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
EP0635575A1 (de) * 1993-07-22 1995-01-25 Wallac Oy Monoklonale Antikörper gegen Epitope in freiem uber nicht in Alpha-1-antichymotrypsin komplexiertem Prostata spezifisches Antigen
CA2286090C (en) * 1997-04-30 2013-01-08 Hybritech Incorporated Forms of prostate specific antigen and methods for their detection
US5994085A (en) * 1997-08-26 1999-11-30 Cantor; Thomas L. Methods and devices for detecting non-complexed prostate specific antigen
FR2780791B1 (fr) * 1998-07-03 2000-09-01 Bio Merieux Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre
US6482599B1 (en) * 1999-04-30 2002-11-19 Hybritech Incorporated Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such

Also Published As

Publication number Publication date
AU2001250470A1 (en) 2001-10-23
FR2807438B1 (fr) 2004-09-17
EP1272525A1 (de) 2003-01-08
DE60122306T2 (de) 2007-08-30
WO2001077180A1 (fr) 2001-10-18
PT1272525E (pt) 2006-12-29
US20030153017A1 (en) 2003-08-14
CA2405637A1 (fr) 2001-10-18
ATE336513T1 (de) 2006-09-15
US20070020710A1 (en) 2007-01-25
ES2269376T3 (es) 2007-04-01
EP1272525B1 (de) 2006-08-16
FR2807438A1 (fr) 2001-10-12

Similar Documents

Publication Publication Date Title
ATE432947T1 (de) Menschliche antikörper als detektionsreagenzien
HK1099360A1 (en) Assay
JP2004528574A5 (de)
MXPA05005288A (es) Inmunoanalisis no competitivo para analitos pequenos.
ATE228247T1 (de) Testreagentien und testvorrichtungen
AU2002304640A1 (en) Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
PL1836500T3 (pl) Sposoby i testy do rozróżniania między różnymi postaciami chorób i zaburzeń cechujących się małopłytkowością i/lub samoistną interakcją między czynnikiem von Willebranda (vWF) a płytkami krwi
ATE274699T1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
DE69418284D1 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
EP1627038A4 (de) Biochipsysteme auf mikropartikelbasis und verwendungen davon
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
DE69615576D1 (de) Polyklonaler antikörper gegen tryptase und reinigungsverfahren zur verwendung in einem immunoassay für menschliche tryptase
DE60235011D1 (de) Assays für den präimplantationsfaktor und präimplantationsfaktorpeptide
ATE405837T1 (de) Festphase immunochromatographische testverfahren
RU2008130888A (ru) Мас-2вр как маркер для диагностики рака желудка
ATE405830T1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
DE60122306D1 (de) Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen
WO2006060188A3 (en) Anti-tenascin monoclonal antibody immunoassays and diagnostic kits
ATE259065T1 (de) Verfahren zum nachweis von helicobacter pylori und heilmanii
YU15401A (sh) Antitela visokog afiniteta
DE69930843D1 (de) Verfahren zum bestimmen von autoantikörpern
WO2006132809A3 (en) Monoclonal antibody reagents
ATE434185T1 (de) Immunoassay für h. pylori in fäkalienproben mit hilfe von gattungsspezifischen antikörpern
ATE526582T1 (de) Generisches verfahren für latex- agglutinationstests

Legal Events

Date Code Title Description
8364 No opposition during term of opposition